vaccin

Understanding the Rise of Shingles and Its Implications

Each year, around 90,000 people in the Netherlands face shingles, a painful viral illness that can lead to severe consequences. Shingles emerge as blisters that can cause an intense burning sensation and itchiness, primarily affecting older adults.

The Aging Population and Shingles

With the Netherlands experiencing rapid aging in the coming decades, the prevalence of shingles is expected to increase. Public health experts predict a significant rise in cases as the number of older adults grows, posing a challenge to healthcare systems already strained by demographic shifts.

vaccination: A Preventive Measure

A licensed vaccine, Shingrix, offers long-term and effective protection against shingles. Unfortunately, its high cost means it is not covered by statutory health insurance, requiring individuals to pay nearly €400 to receive the vaccine through municipal health services.

The disparity in healthcare access is noted by GGD-physicians and senior organizations, who worry about a widening health gap among older populations. Countries like Germany, France, and the UK offer state-funded vaccinations, while the Netherlands hesitates, citing cost concerns despite recommendations from health advisors.

The High Cost of Chronic Pain

Postherpetic neuralgia, a persistent nerve pain following a shingles outbreak, affects 10-25% of patients. Treating this condition often involves costly and side-effect-prone medications like methadone and antidepressants, challenging patients and healthcare budgets.

Why Prevention is Better Than Cure

Experts argue that vaccination is a more effective approach than managing chronic pain after an outbreak. “We witness people opting out of vaccination due to the cost,” shares Timo Boelsums, an infectious disease physician. The preventative approach not only alleviates suffering but also reduces healthcare costs for advanced treatments and long-term care.

Medicine Shortages and Healthcare Strain

Shortages of essential medications for managing chronic pain are becoming more frequent. These shortages escalate healthcare costs further and strain resources, driving the argument for more accessible preventive measures.

The Human Cost of Shingles

Real-life stories highlight the severe impact of shingles. Some individuals suffering from postherpetic neuralgia have even resorted to euthanasia due to the unbearable pain. As stories like that of Rob Schutte, an Enschede man who wished for access to vaccination in neighboring Germany, come to light, the need for accessible preventive healthcare becomes more pressing.

Current Discussions and Future Directions

Karremans, the Dutch Minister of Health, is facing calls from legislators to include shingles in the national vaccination program. The forthcoming policy review will determine if the high costs can be justified by long-term savings in healthcare.

Frequently Asked Questions About Shingles and Vaccination

What is shingles?

Shingles is a painful viral infection resulting from the reactivation of the varicella-zoster virus, causing a rash and blisters.

How effective is the Shingrix vaccine?

Shingrix is highly effective at preventing shingles and reducing the risk of postherpetic neuralgia in older adults.

Why isn’t the Shingrix vaccine covered by Dutch health insurance?

The high cost is a significant barrier despite the vaccine’s proven cost-effectiveness in reducing long-term healthcare expenses.

Interactive Elements

Take Action: Join the Conversation

Your health matters. Share your thoughts in the comments or subscribe to our newsletter for more insights on healthcare innovations. Together, we can advocate for better access to preventive healthcare measures.